Which anabolic compounds produce the strongest synergistic effect when stacked with Drostanolone Propionate 100mg/ml?

Testosterone Propionate, Trenbolone Acetate, and Oxandrolone each create distinct and complementary synergies with Drostanolone Propionate. Testosterone provides the anabolic base; Trenbolone Acetate adds nitrogen retention and nutrient partitioning; Oxandrolone contributes strength without water. Drostanolone Propionate ties all three together by suppressing SHBG — raising free androgen fractions across every compound simultaneously — while contributing zero aromatisation load to the combined stack.

How does stacking Drostanolone Propionate with a testosterone base amplify overall cycle results beyond what either compound achieves alone?

Drostanolone Propionate displaces testosterone from SHBG binding sites, shifting more testosterone into the free, receptor-active fraction without requiring a testosterone dose increase. This SHBG suppression effect means the same testosterone dose delivers a greater anabolic signal at the tissue level. Additionally, Drostanolone Propionate's non-aromatising character allows oestrogen-sensitive athletes to maintain higher total androgen exposure without escalating ancillary anti-oestrogen requirements.

What is the most effective three-compound combination that makes the best use of Drostanolone Propionate's synergistic properties for a contest-prep cycle?

A classic contest-preparation triad pairs Drostanolone Propionate with Testosterone Propionate and Trenbolone Acetate, all short-ester compounds. Drostanolone handles SHBG suppression and anti-oestrogenic tissue hardening; Testosterone maintains endogenous hormonal balance; Trenbolone Acetate drives muscle density and fat oxidation. All three share compatible every-other-day injection schedules, producing a synchronised serum profile that simplifies dosing and cycle-exit management.

How does the 100mg/ml concentration of Kim Pharma's Drostanolone Propionate compare to higher-concentration versions for precision dosing in a stack?

At 100mg/ml — the lowest concentration tier in this category — each 0.1ml increment equals exactly 10mg, giving athletes granular control when fine-tuning their individual compound ratios within a multi-drug stack. Higher-concentration formulations compress volume but widen the dosing margin per graduation; for athletes balancing three or more compounds simultaneously, the 100mg/ml format offers proportionally finer dose adjustment. Kim Pharma's HPLC verification confirms concentration accuracy at this baseline strength.

How should a 10ml vial of Kim Pharma Drostanolone Propionate 100mg/ml be stored after the first draw to maintain sterility throughout a multi-week stacking protocol?

After first puncture, store the vial upright at room temperature (15–25 °C), away from direct light and heat sources; refrigeration is not required but acceptable if ambient temperature exceeds 25 °C consistently. Wipe the rubber stopper with a fresh 70 % isopropyl alcohol swab before every draw, and use a new sterile needle for each access. The 10ml multi-dose format is designed to support repeated sterile draws across a full protocol without compromising the remaining contents. (2) angle_used

Best-Selling

Kim Pharma

Drostanolone Propionate 100mg/ml 10ml Vial by Kim Pharma

Name: Drostanolone Propionate 100mg/ml 10ml Vial by Kim Pharma
Brand: Kim Pharma
SKU: INJ-DROP-KIM-100-024
Price: 50.00 EUR
Availability: InStock

Hilma Biocare Drostanolone Propionate 100mg/ml is a short-ester injectable androgen formulated at a clinically practical concentration, distinguished by its predictable pharmacokinetic profile — characterised by a half-life of approximately 2–3 days that governs injection scheduling and steady-state accumulation across the cycle. Because the propionate ester dictates such a defined release window, serum concentration behaviour is measurable, repeatable, and directly linked to dosing intervals rather than to subjective response. Batch-release documentation — including HPLC-confirmed potency and LAL endotoxin data — is supplied lot-specific, with each 10ml multi-dose vial manufactured under EU GMP-compliant aseptic conditions.

€50.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Suppresses SHBG binding, converting a greater proportion of co-administered androgens into their biologically active free fraction
Contributes zero aromatisation, allowing the combined stack's oestrogen load to remain manageable without adding ancillary compounds
Short 2–3 day propionate half-life aligns naturally with every-other-day short-ester stack partners, producing synchronised serum windows
DHT-derived hardening effect on subcutaneous and connective tissue visually enhances muscle density achieved by primary mass agents in the protocol
100mg/ml concentration provides the finest per-graduation dose control available in this compound category — critical when balancing multiple stacked drugs
One 10ml vial delivers 1,000mg total, covering a complete EOD stack protocol without mid-cycle resupply

Phase	Dosage	Note
Synergy entry (Weeks 1–2)	50–75mg every other day	Establish baseline alongside testosterone base before adding third compound
Full stack (Weeks 3–8)	100mg every other day	Co-administer with Testosterone Propionate 100mg EOD; add Trenbolone Acetate or Oxandrolone if protocol calls for it
Pre-competition taper (Weeks 9–10)	50mg every other day	Maintain SHBG suppression and hardening effect while reducing total androgen load ahead of cycle exit
Stack exit	Final injection Day 70	Propionate ester clears within days; schedule PCT in coordination with all other short-ester compounds in the stack

Drostanolone Propionate as a Synergistic Stack Anchor

Drostanolone Propionate is an injectable DHT-derived androgen that functions, within a multi-compound protocol, as a pharmacological multiplier — augmenting the active fraction of co-administered androgens rather than acting as a standalone accumulation agent. Its structural resistance to aromatase means it contributes no oestrogen load to the stack while simultaneously competing with other androgens for sex-hormone-binding globulin (SHBG) occupancy. That SHBG competition displaces bound testosterone and other co-administered compounds into the free, biologically active fraction, effectively stretching the pharmacological yield of every milligram already in the protocol.

Which Compounds Gain the Most From Co-Administration

Testosterone esters pair with Drostanolone Propionate most predictably: the propionate variant's 2–3 day half-life (established by pharmacokinetic assay) aligns injection frequency naturally with short-ester testosterone schedules, maintaining co-incident peak windows. Compared to stacking Masteron with longer-ester testosterone preparations, the short-ester combination produces a tighter, more synchronised serum curve that simplifies dose adjustment and cycle-exit timing. Trenbolone Acetate is a second high-synergy partner; Drostanolone Propionate's anti-oestrogenic tissue effect counterbalances prolactin-adjacent side-effect profiles without requiring the addition of a separate ancillary agent. Anavar (Oxandrolone) rounds out a classic contest-prep triad: Drostanolone Propionate supplies androgenic hardness and SHBG suppression, Anavar contributes nitrogen retention, and the testosterone base maintains endogenous hormonal signalling — three distinct mechanisms operating simultaneously.

How Stacking Amplifies Overall Tissue-Level Results

The amplification effect operates through three parallel pathways: first, Drostanolone Propionate occupies androgen receptors in target tissue while the SHBG-displaced free testosterone simultaneously activates additional receptor pools — receptor coverage expands without a proportional increase in total injected dose. Second, because Drostanolone Propionate carries no aromatisation liability, co-administered testosterone dosage can be maintained or modestly increased without triggering oestrogen-driven water retention, preserving the aesthetic definition that cutting athletes require. Third, the hardening effect on subcutaneous tissue — attributable to its DHT-derived structure acting on androgen-sensitive sebaceous and connective tissue — visually magnifies the muscle density achieved through the primary anabolic compound in the stack.

Quality Infrastructure Supporting Stack Consistency

Reliable synergy across a multi-week protocol demands batch-to-batch concentration accuracy; a 10 % concentration variance in any single vial misaligns the carefully calculated dose ratios between stacked compounds. Kim Pharma addresses this through reversed-phase HPLC quantification on every production lot, with results documented against a traceable reference standard; LAL endotoxin assay confirms parenteral safety before release. Each 10ml vial at 100mg/ml delivers 1,000mg total — sufficient for a 10-week stack protocol at 100mg every-other-day dosing without mid-cycle supply interruption.

Usage

Plan your stack ratios first.: Before drawing any compound, calculate the intended weekly dose of every stacked agent and confirm the total androgen load is within your planned range — Drostanolone Propionate's SHBG-suppression effect will raise the effective potency of co-administered compounds beyond their nominal dose.
Verify the lot.: Check the vial's batch number against Kim Pharma's HPLC potency documentation; confirm concentration is 100mg/ml before computing injection volumes for the stack.
Prepare injection equipment.: Use a fresh 21–23G drawing needle to load the syringe, then swap to a 23–25G injection needle; wipe the rubber stopper with 70 % isopropyl alcohol before every draw.
Calculate combined injection volume.: If Drostanolone Propionate and Testosterone Propionate share an EOD injection day, both can be drawn into a single syringe — confirm oil carrier compatibility first and keep total volume under 2ml per site.
Inject into alternating sites.: Rotate between glutes, quads, and delts on successive EOD injections to prevent localised tissue build-up across a 10-week protocol.
Track stack response weekly.: Log bodyweight, visible subcutaneous water, and subjective hardness at the same day each week; Drostanolone Propionate's synergistic SHBG effect should produce measurable free-androgen-driven changes within the first two weeks of the full-stack phase.

Warnings

Contraindications:

Not suitable for individuals with androgen-sensitive prostate conditions, existing cardiovascular disease, hepatic impairment, or elevated haematocrit baseline. Women and adolescents should not use this compound. Do not initiate a multi-compound stack incorporating Drostanolone Propionate without a full pre-cycle blood panel covering testosterone, SHBG, LH, FSH, haematocrit, and lipid profile.

Side Effects:

Androgenic effects — scalp hair thinning, acne, increased body hair — are heightened in DHT-sensitive individuals and are amplified in a stack where free androgen levels are elevated by SHBG suppression. Cardiovascular risk increases proportionally when stacking multiple androgens; HDL suppression is cumulative across co-administered compounds. Monitor blood pressure throughout the stack cycle.

Monitoring:

Obtain mid-cycle bloodwork (minimum: haematocrit, lipid panel, liver enzymes, free testosterone) at week 4–5 of the stacking protocol. Dose adjustments across all stacked compounds should be made together, not in isolation, since Drostanolone Propionate's SHBG effect shifts the pharmacological activity of every compound in the protocol.

PCT:

Because Drostanolone Propionate's propionate ester clears rapidly, PCT timing is governed by the longest-ester compound in the stack. Once all stacked compounds have cleared, initiate a structured PCT protocol (typically Nolvadex and/or Clomid) to restore endogenous testosterone production suppressed by the combined androgenic load.

Frequently asked questions

Which anabolic compounds produce the strongest synergistic effect when stacked with Drostanolone Propionate 100mg/ml?: Testosterone Propionate, Trenbolone Acetate, and Oxandrolone each create distinct and complementary synergies with Drostanolone Propionate. Testosterone provides the anabolic base; Trenbolone Acetate adds nitrogen retention and nutrient partitioning; Oxandrolone contributes strength without water. Drostanolone Propionate ties all three together by suppressing SHBG — raising free androgen fractions across every compound simultaneously — while contributing zero aromatisation load to the combined stack.
How does stacking Drostanolone Propionate with a testosterone base amplify overall cycle results beyond what either compound achieves alone?: Drostanolone Propionate displaces testosterone from SHBG binding sites, shifting more testosterone into the free, receptor-active fraction without requiring a testosterone dose increase. This SHBG suppression effect means the same testosterone dose delivers a greater anabolic signal at the tissue level. Additionally, Drostanolone Propionate's non-aromatising character allows oestrogen-sensitive athletes to maintain higher total androgen exposure without escalating ancillary anti-oestrogen requirements.
What is the most effective three-compound combination that makes the best use of Drostanolone Propionate's synergistic properties for a contest-prep cycle?: A classic contest-preparation triad pairs Drostanolone Propionate with Testosterone Propionate and Trenbolone Acetate, all short-ester compounds. Drostanolone handles SHBG suppression and anti-oestrogenic tissue hardening; Testosterone maintains endogenous hormonal balance; Trenbolone Acetate drives muscle density and fat oxidation. All three share compatible every-other-day injection schedules, producing a synchronised serum profile that simplifies dosing and cycle-exit management.
How does the 100mg/ml concentration of Kim Pharma's Drostanolone Propionate compare to higher-concentration versions for precision dosing in a stack?: At 100mg/ml — the lowest concentration tier in this category — each 0.1ml increment equals exactly 10mg, giving athletes granular control when fine-tuning their individual compound ratios within a multi-drug stack. Higher-concentration formulations compress volume but widen the dosing margin per graduation; for athletes balancing three or more compounds simultaneously, the 100mg/ml format offers proportionally finer dose adjustment. Kim Pharma's HPLC verification confirms concentration accuracy at this baseline strength.
How should a 10ml vial of Kim Pharma Drostanolone Propionate 100mg/ml be stored after the first draw to maintain sterility throughout a multi-week stacking protocol?: After first puncture, store the vial upright at room temperature (15–25 °C), away from direct light and heat sources; refrigeration is not required but acceptable if ambient temperature exceeds 25 °C consistently. Wipe the rubber stopper with a fresh 70 % isopropyl alcohol swab before every draw, and use a new sterile needle for each access. The 10ml multi-dose format is designed to support repeated sterile draws across a full protocol without compromising the remaining contents. (2) angle_used

Manufacturer

Kim Pharma's product line architecture is organised around therapeutic-use categories rather than individual molecules — a portfolio philosophy that positions Drostanolone Propionate not as a standalone listing but as one node within a structured injectable androgen range designed to support multi-compound protocols end to end. The product portfolio spans short-ester androgens, long-ester mass agents, and cutting-phase compounds, with each SKU manufactured to a common analytical standard so that concentration accuracy is consistent across every vial an athlete sources from the same brand for a single stack cycle. This cross-product concentration reliability is maintained through HPLC batch verification applied uniformly to all formulations in the range — not selectively to flagship products — ensuring that Drostanolone Propionate's documented 100mg/ml strength is held to the same analytical accountability as every other injectable in the Kim Pharma catalogue.

Product details

Brand	Kim Pharma
Active ingredient	drostanolone propionate
Strength	100 mg
Form	Vial
Pack size	1 piece
Item number	INJ-DROP-KIM-100-024

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Optimal Dosage

Propha-Masteron 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Propha-Masteron is an oil-based injectable solution delivering Drostanolone Propionate at 100mg/ml, distinguished by its capacity to bypass hepatic first-pass metabolism entirely — a pharmacokinetic advantage that oral androgen compounds cannot replicate. Each 10ml multi-dose vial provides a full cycle's supply of pharmaceutical-grade active, with systemic absorption occurring directly through intramuscular tissue into the bloodstream. Quality assurance is built into every lot: HPLC potency verification, LAL endotoxin screening, and GMP-certified filling suites are standard — not optional — at Beligas Pharmaceuticals.

€46.00

Masten-100 100mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Fast Acting

Masten-100 100mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Masten-100 is a fast-acting injectable androgenic compound delivering Drostanolone Propionate at 100mg/ml in single-dose 1ml ampoules, specifically engineered for rapid tissue uptake and measurable efficacy within the first days of administration. The propionate ester's short carbon chain enables peak plasma concentrations to establish quickly — typically within 24–48 hours of the first injection — making it one of the fastest-onset drostanolone formulations available. Every lot is released only after HPLC potency confirmation and LAL endotoxin screening; sterility is assured via Ph. Eur. 2.6.1-compliant testing conducted at BM Pharmaceuticals' GMP-certified facility.

€47.00

High Concentration

MasterTrex 150mg/ml 10ml Vial by Concentrex Labs

MasterTrex is a high-concentration Drostanolone Propionate injectable, formulated at 150 mg/ml in a 10 ml multi-dose vial and engineered for athletes who demand precise, schedule-driven injection timing across their cutting or pre-contest phase. At 150 mg/ml, each draw delivers a clinically meaningful dose in a compact volume, making every-other-day or every-third-day scheduling straightforward without excess injection site load. Quality is locked in at batch level: HPLC-quantified potency verification and LAL endotoxin testing are completed before any MasterTrex vial leaves the Concentrex Labs facility.

€50.00

Brand Quality

Masteron 100 100mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Masteron 100 is a drostanolone propionate injectable solution at 100mg/ml in a 10ml multi-dose vial, specifically suited to frontloading protocols that compress the time-to-steady-state window at the opening of a cycle. Because the propionate ester releases active drostanolone within a short half-life of approximately 2–3 days, calculated loading doses can bring circulating androgen levels to the target therapeutic range within the first 72 hours rather than waiting the usual week or more. Dragon-Pharma batch-releases every vial only after HPLC potency verification and LAL endotoxin clearance — two independent quality gates applied sequentially before product leaves the facility.

€42.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00